For help on how to get the results you want, see our search tips.
455 results
-
List item
Human medicine European public assessment report (EPAR): Pazenir (updated)
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,
, Revision: 4, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Lojuxta (updated)
Lomitapide, Hypercholesterolemia
Date of authorisation: 31/07/2013,
, 
, Revision: 12, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Takhzyro (updated)
lanadelumab, Angioedemas, Hereditary
Date of authorisation: 22/11/2018,, 
, 
, Revision: 2, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Zalasta (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 27/09/2007,, Revision: 17, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Actavis (updated)
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 15, Authorised, Last updated: 24/03/2020
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 9, Authorised, Last updated: 24/03/2020
-
List item
Human medicine European public assessment report (EPAR): Atriance (updated)
nelarabine, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 22/08/2007,, , Revision: 23, Authorised, Last updated: 23/03/2020
-
List item
Human medicine European public assessment report (EPAR): Ambrisentan Mylan (updated)
ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/06/2019,, Revision: 1, Authorised, Last updated: 20/03/2020
-
List item
Human medicine European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) (updated)
reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain, Influenza, Human
Date of authorisation: 20/05/2016,, 
, Revision: 4, Authorised, Last updated: 20/03/2020
-
List item
Human medicine European public assessment report (EPAR): Cinacalcet Mylan (updated)
cinacalcet hydrochloride, Hyperparathyroidism, Secondary, Hypercalcemia
Date of authorisation: 19/11/2015,, Revision: 6, Authorised, Last updated: 19/03/2020
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Actavis Group (updated)
levetiracetam, Epilepsy
Date of authorisation: 04/12/2011,, Revision: 13, Authorised, Last updated: 19/03/2020
-
List item
Human medicine European public assessment report (EPAR): Deferiprone Lipomed (updated)
Deferiprone, Iron Overload, beta-Thalassemia
Date of authorisation: 19/09/2018,, Revision: 2, Authorised, Last updated: 19/03/2020
-
List item
Human medicine European public assessment report (EPAR): Spinraza (updated)
nusinersen sodium, Muscular Atrophy, Spinal
Date of authorisation: 30/05/2017,, , , Revision: 9, Authorised, Last updated: 18/03/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)
clopidogrel hydrogen sulphate, Acute Coronary Syndrome, Peripheral Vascular Diseases, Myocardial Infarction, Stroke
Date of authorisation: 27/07/2009,, Revision: 14, Authorised, Last updated: 17/03/2020
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (updated)
efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018,, Revision: 4, Authorised, Last updated: 17/03/2020
-
List item
Human medicine European public assessment report (EPAR): Ivozall (updated)
clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/11/2019,, Authorised, Last updated: 16/03/2020
-
List item
Human medicine European public assessment report (EPAR): Ritonavir Mylan (updated)
ritonavir, HIV Infections
Date of authorisation: 09/11/2017,, Revision: 6, Authorised, Last updated: 16/03/2020
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Hospira (updated)
levetiracetam, Epilepsy
Date of authorisation: 07/01/2014,, Revision: 14, Authorised, Last updated: 12/03/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya) (updated)
clopidogrel hydrochloride,
Date of authorisation: 20/09/2009,, Revision: 11, Authorised, Last updated: 11/03/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel BGR (previously Zylagren) (updated)
clopidogrel hydrogen sulphate, Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 17, Authorised, Last updated: 11/03/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)
clopidogrel hydrochloride, Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 14, Authorised, Last updated: 11/03/2020
-
List item
Human medicine European public assessment report (EPAR): Increlex (updated)
Mecasermin, Laron Syndrome
Date of authorisation: 02/08/2007,, , Revision: 21, Authorised, Last updated: 11/03/2020
-
List item
Human medicine European public assessment report (EPAR): Zyllt (updated)
clopidogrel hydrogen sulphate, Peripheral Vascular Diseases, Stroke, Acute Coronary Syndrome, Myocardial Infarction
Date of authorisation: 28/09/2009,, Revision: 13, Authorised, Last updated: 10/03/2020
-
List item
Human medicine European public assessment report (EPAR): Cometriq (updated)
cabozantinib, Thyroid Neoplasms
Date of authorisation: 21/03/2014,, , , Revision: 17, Authorised, Last updated: 10/03/2020
-
List item
Human medicine European public assessment report (EPAR): Yargesa (updated)
miglustat, Gaucher Disease
Date of authorisation: 22/03/2017,, Revision: 3, Authorised, Last updated: 10/03/2020